# OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease

> **NCT01367145** · PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 71 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** OMACOR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01367145
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-11
- **Final completion:** 2014-03
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2014-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367145, "OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01367145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*